Your browser doesn't support javascript.
loading
An examination of the moderating effects of neurophysiology on treatment outcomes from cognitive training in schizophrenia-spectrum disorders.
Best, Michael W; Milanovic, Melissa; Shamblaw, Amanda L; Muere, Abi; Lambe, Laura J; Hong, Irene K; Haque, Mashal K; Bowie, Christopher R.
Afiliação
  • Best MW; Department of Psychology, Queen's University, Kingston, Ontario, Canada.
  • Milanovic M; Department of Psychology, Queen's University, Kingston, Ontario, Canada.
  • Shamblaw AL; Department of Psychology, Queen's University, Kingston, Ontario, Canada.
  • Muere A; Department of Psychology, Queen's University, Kingston, Ontario, Canada.
  • Lambe LJ; Department of Psychology, Queen's University, Kingston, Ontario, Canada.
  • Hong IK; Department of Psychology, Queen's University, Kingston, Ontario, Canada.
  • Haque MK; Department of Psychology, Queen's University, Kingston, Ontario, Canada.
  • Bowie CR; Department of Psychology, Queen's University, Kingston, Ontario, Canada; Centre for Addiction and Mental Health, Toronto, Ontario, Canada. Electronic address: bowiec@queensu.ca.
Int J Psychophysiol ; 154: 59-66, 2020 08.
Article em En | MEDLINE | ID: mdl-30776393
ABSTRACT

BACKGROUND:

Impairments in neurocognition and community functioning are core features of schizophrenia and cognitive training techniques have been developed with the aim of improving these impairments. While cognitive training has produced reliable improvements in neurocognition and functioning, little is known about factors that moderate treatment response. Electroencephalographic (EEG) measures provide a neurophysiological indicator of cognitive functions that may moderate treatment outcomes from cognitive training.

METHODS:

Data from a clinical trial comparing two cognitive training approaches in schizophrenia-spectrum disorders were utilized in the current report. Cluster analysis was conducted to identify participant clusters based on baseline P300, mismatch negativity (MMN), and theta power during an n-back task, and the EEG measures were also examined as continuous predictors of treatment response.

RESULTS:

Three clusters were identified based on the baseline EEG variables; however, there were no significant differences in treatment response across the three clusters. Higher P300 amplitude and theta power during the n-back at baseline were significantly associated with greater improvements in a cognitive composite score post-treatment. None of the EEG measures were significantly associated with treatment outcomes in specific cognitive domains or community functioning. Change in EEG measures from baseline to post-treatment was not significantly associated with durability of cognitive or functional change at 12-week follow-up.

CONCLUSIONS:

Clusters derived from the EEG measures were not significantly associated with either neurocognitive or functional outcomes. P300 and n-back theta power may be associated with learning-related processes, which are important for acquisition and retention of skills during cognitive training programs. Future research should aim to identify at an individual level who is likely to respond to specific forms of cognitive enhancement.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Transtornos Cognitivos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Transtornos Cognitivos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article